Cerus Corp. (CERS)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
William M. Greenman
Employees:
460
2550 STANWELL DRIVE, CONCORD, CA 94520
9252886000

Cerus Corporation focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America and internationally.

Data derived from most recent annual or quarterly report
Market Cap 526.94 Million Shares Outstanding177.421 Million Avg 30-day Volume 1.844 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.05
Price to Revenue7.3121 Debt to Equity0.8108 EBITDA-45.986 Million
Price to Book Value13.7843 Operating Margin-30.6774 Enterprise Value1.107 Billion
Current Ratio2.382 EPS Growth0.135 Quick Ratio1.967
1 Yr BETA 1.684 52-week High/Low 5.95 / 2.36 Profit Margin-34.0877
Operating Cash Flow Growth18.8682 Altman Z-Score-0.5393 Free Cash Flow to Firm -41.642 Million
Earnings Report2023-05-10
View SEC Filings from CERS instead.

View recent insider trading info

Cerus Corp. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding CERS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CERS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-03-14 by MOORE CAROL
  • 4: filed on 2023-03-14 by JAYARAMAN VIVEK K
  • 4: filed on 2023-03-14 by MENARD CHRYSTAL
  • 4: filed on 2023-03-14 by GREENMAN WILLIAM MARINER
  • 4: filed on 2023-03-14 by GREEN KEVIN DENNIS
  • 4: filed on 2023-03-14 by CORASH LAURENCE M
  • 4: filed on 2023-03-14 by BENJAMIN RICHARD J
  • 4: filed on 2023-03-03 by MOORE CAROL
  • 4: filed on 2023-03-03 by MENARD CHRYSTAL
  • 4: filed on 2023-03-03 by JAYARAMAN VIVEK K

    • Events (8k)

  • 8-K: filed on 2023-03-10:
    Item 8.01: Other Events
  • 8-K: filed on 2023-02-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-05:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-02:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-02-22:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-23:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
  • 8-K: filed on 2021-08-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    172.2 Thousand total shares from 15 transactions

    Exercise Derivative Conversion (M)

    442 Thousand total shares from 14 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    CORASH LAURENCE M CHIEF SCIENTIFIC OFFICER

    • Officer
    		 9,039,502 2023-03-12 2

    BENJAMIN RICHARD J CHIEF MEDICAL OFFICER

    • Officer
    		 1,413,269 2023-03-12 3

    GREENMAN WILLIAM MARINER PRESIDENT AND CEO

    • Officer
    • Director
    		 10,609,994 2023-03-12 2

    GREEN KEVIN DENNIS CHIEF FINANCIAL OFFICER

    • Officer
    		 1,732,683 2023-03-12 3

    MENARD CHRYSTAL CHIEF LEGAL OFFICER

    • Officer
    		 1,391,770 2023-03-12 3

    MOORE CAROL SVP REG. & QUALITY

    • Officer
    		 1,660,104 2023-03-12 2

    JAYARAMAN VIVEK K CHIEF OPERATING OFFICER

    • Officer
    		 2,625,218 2023-03-12 2

    SCHULZE GAIL

    • Director
    		 73,570 2022-12-28 2

    SWISHER DANIEL N JR

    • Director
    		 113,808 2022-11-10 2

    SHAN HUA

    • Director
    		 0 2022-07-01 2

    BJERKHOLT ERIC

    • Director
    		 116,999 2022-06-01 1

    NACHTSHEIM JAMI K

    • Director
    		 106,228 2022-06-01 1

    WITNEY FRANK

    • Director
    		 159,925 2022-06-01 1

    MOORE TIMOTHY L.

    • Director
    		 104,939 2022-06-01 1

    LUCENA ANN

    • Director
    		 0 2021-08-06 0

    ANDERSON TIMOTHY B

    • Director
    		 213,993 2021-06-01 0

    COZADD BRUCE C

    • Director
    		 18,921 2017-06-06 0

    HOGEBOOM CASPAR JAN PRESIDENT, CERUS EUROPE

    • Officer
    		 0 2015-12-10 0

    CASSIN BJ

    • Director
    		 332,225 2013-11-04 0

    ERVIN HOWARD G VICE PRESIDENT, LEGAL AFFAIRS

    • Officer
    		 42,846 2013-01-07 0

    GLASSELL CLAES EXECUTIVE OFFICER AND DIRECTOR

    • Officer
    • Director
    		 0 2011-04-01 0

    ROHN WILLIAM R

    • Director
    		 0 2011-01-03 0

    DAWSON WILLIAM J CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2009-01-12 0

    COOK DAVID N VICE PRESIDENT, R & D

    • Officer
    		 30,000 2007-10-01 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    MENARD CHRYSTAL - Officer CHIEF LEGAL OFFICER

    		2023-03-14 19:50:56 -0400 2023-03-13 S 5,758 $2.80 d 349,530 direct yes 1.7241 -3.4483 3.7931 5 -3.4483 6

    GREEN KEVIN DENNIS - Officer CHIEF FINANCIAL OFFICER

    		2023-03-14 19:43:11 -0400 2023-03-13 S 7,501 $2.80 d 435,963 direct yes 1.7241 -3.4483 3.7931 5 -3.4483 6

    GREEN KEVIN DENNIS - Officer CHIEF FINANCIAL OFFICER

    		2023-03-14 19:43:11 -0400 2023-03-13 S 9,662 $2.80 d 421,797 direct yes 1.7241 -3.4483 3.7931 5 -3.4483 6

    JAYARAMAN VIVEK K - Officer CHIEF OPERATING OFFICER

    		2023-03-14 19:56:33 -0400 2023-03-13 S 8,791 $2.80 d 658,070 direct yes 1.7241 -3.4483 3.7931 5 -3.4483 6

    JAYARAMAN VIVEK K - Officer CHIEF OPERATING OFFICER

    		2023-03-14 19:56:33 -0400 2023-03-13 S 16,565 $2.80 d 641,861 direct yes 1.7241 -3.4483 3.7931 5 -3.4483 6

    CORASH LAURENCE M - Officer CHIEF SCIENTIFIC OFFICER

    		2023-03-14 19:38:59 -0400 2023-03-13 S 9,597 $2.80 d 2,250,579 direct yes 1.7241 -3.4483 3.7931 5 -3.4483 6

    CORASH LAURENCE M - Officer CHIEF SCIENTIFIC OFFICER

    		2023-03-14 19:38:59 -0400 2023-03-13 S 5,745 $2.80 d 2,261,501 direct yes 1.7241 -3.4483 3.7931 5 -3.4483 6

    MENARD CHRYSTAL - Officer CHIEF LEGAL OFFICER

    		2023-03-14 19:50:56 -0400 2023-03-13 S 9,710 $2.80 d 338,621 direct yes 1.7241 -3.4483 3.7931 5 -3.4483 6

    BENJAMIN RICHARD J - Officer CHIEF MEDICAL OFFICER

    		2023-03-14 19:34:51 -0400 2023-03-13 S 10,000 $2.78 d 347,439 direct 1.7241 -3.4483 3.7931 5 -3.4483 6

    BENJAMIN RICHARD J - Officer CHIEF MEDICAL OFFICER

    		2023-03-14 19:34:51 -0400 2023-03-13 S 9,606 $2.80 d 346,519 direct yes 1.7241 -3.4483 3.7931 5 -3.4483 6

    BENJAMIN RICHARD J - Officer CHIEF MEDICAL OFFICER

    		2023-03-14 19:34:51 -0400 2023-03-13 S 5,747 $2.80 d 357,439 direct yes 1.7241 -3.4483 3.7931 5 -3.4483 6

    MOORE CAROL - Officer SVP REG. & QUALITY

    		2023-03-14 20:00:27 -0400 2023-03-13 S 3,350 $2.80 d 415,915 direct yes 1.7241 -3.4483 3.7931 5 -3.4483 6

    MOORE CAROL - Officer SVP REG. & QUALITY

    		2023-03-14 20:00:27 -0400 2023-03-13 S 9,728 $2.80 d 407,598 direct yes 1.7241 -3.4483 3.7931 5 -3.4483 6

    GREENMAN WILLIAM MARINER - Director - Officer PRESIDENT AND CEO

    		2023-03-14 19:47:42 -0400 2023-03-13 S 22,732 $2.80 d 2,658,346 direct 1.7241 -3.4483 3.7931 5 -3.4483 6

    GREENMAN WILLIAM MARINER - Director - Officer PRESIDENT AND CEO

    		2023-03-14 19:47:42 -0400 2023-03-13 S 37,748 $2.80 d 2,616,411 direct 1.7241 -3.4483 3.7931 5 -3.4483 6

    GREENMAN WILLIAM MARINER - Director - Officer PRESIDENT AND CEO

    		2023-03-14 19:47:42 -0400 2023-03-12 M 107,525 a 2,654,159 direct 1.7241 -3.4483 3.7931 5 -3.4483 6

    MENARD CHRYSTAL - Officer CHIEF LEGAL OFFICER

    		2023-03-14 19:50:56 -0400 2023-03-12 M 16,667 a 355,288 direct 1.7241 -3.4483 3.7931 5 -3.4483 6

    MENARD CHRYSTAL - Officer CHIEF LEGAL OFFICER

    		2023-03-14 19:50:56 -0400 2023-03-12 M 16,667 d 16,666 direct

    GREENMAN WILLIAM MARINER - Director - Officer PRESIDENT AND CEO

    		2023-03-14 19:47:42 -0400 2023-03-12 M 107,525 d 0 direct

    GREEN KEVIN DENNIS - Officer CHIEF FINANCIAL OFFICER

    		2023-03-14 19:43:11 -0400 2023-03-12 M 23,460 d 0 direct

    MENARD CHRYSTAL - Officer CHIEF LEGAL OFFICER

    		2023-03-14 19:50:56 -0400 2023-03-12 M 23,460 a 348,331 direct 1.7241 -3.4483 3.7931 5 -3.4483 6

    MENARD CHRYSTAL - Officer CHIEF LEGAL OFFICER

    		2023-03-14 19:50:56 -0400 2023-03-12 M 23,460 d 0 direct

    JAYARAMAN VIVEK K - Officer CHIEF OPERATING OFFICER

    		2023-03-14 19:56:33 -0400 2023-03-12 M 25,000 a 666,861 direct 1.7241 -3.4483 3.7931 5 -3.4483 6

    JAYARAMAN VIVEK K - Officer CHIEF OPERATING OFFICER

    		2023-03-14 19:56:33 -0400 2023-03-12 M 25,000 d 25,000 direct

    JAYARAMAN VIVEK K - Officer CHIEF OPERATING OFFICER

    		2023-03-14 19:56:33 -0400 2023-03-12 M 44,200 a 658,426 direct 1.7241 -3.4483 3.7931 5 -3.4483 6

    JAYARAMAN VIVEK K - Officer CHIEF OPERATING OFFICER

    		2023-03-14 19:56:33 -0400 2023-03-12 M 44,200 d 0 direct

    MOORE CAROL - Officer SVP REG. & QUALITY

    		2023-03-14 20:00:27 -0400 2023-03-12 M 11,667 a 419,265 direct 1.7241 -3.4483 3.7931 5 -3.4483 6

    MOORE CAROL - Officer SVP REG. & QUALITY

    		2023-03-14 20:00:27 -0400 2023-03-12 M 11,667 d 11,666 direct

    MOORE CAROL - Officer SVP REG. & QUALITY

    		2023-03-14 20:00:27 -0400 2023-03-12 M 23,460 a 417,326 direct 1.7241 -3.4483 3.7931 5 -3.4483 6

    MOORE CAROL - Officer SVP REG. & QUALITY

    		2023-03-14 20:00:27 -0400 2023-03-12 M 23,460 d 0 direct

    GREENMAN WILLIAM MARINER - Director - Officer PRESIDENT AND CEO

    		2023-03-14 19:47:42 -0400 2023-03-12 M 64,667 a 2,681,078 direct 1.7241 -3.4483 3.7931 5 -3.4483 6

    BENJAMIN RICHARD J - Officer CHIEF MEDICAL OFFICER

    		2023-03-14 19:34:51 -0400 2023-03-12 M 16,667 a 363,186 direct 1.7241 -3.4483 3.7931 5 -3.4483 6

    BENJAMIN RICHARD J - Officer CHIEF MEDICAL OFFICER

    		2023-03-14 19:34:51 -0400 2023-03-12 M 16,667 d 16,666 direct

    BENJAMIN RICHARD J - Officer CHIEF MEDICAL OFFICER

    		2023-03-14 19:34:51 -0400 2023-03-12 M 23,460 a 356,125 direct 1.7241 -3.4483 3.7931 5 -3.4483 6

    BENJAMIN RICHARD J - Officer CHIEF MEDICAL OFFICER

    		2023-03-14 19:34:51 -0400 2023-03-12 M 23,460 d 0 direct

    CORASH LAURENCE M - Officer CHIEF SCIENTIFIC OFFICER

    		2023-03-14 19:38:59 -0400 2023-03-12 M 16,667 a 2,267,246 direct 1.7241 -3.4483 3.7931 5 -3.4483 6

    CORASH LAURENCE M - Officer CHIEF SCIENTIFIC OFFICER

    		2023-03-14 19:38:59 -0400 2023-03-12 M 16,667 d 16,666 direct

    CORASH LAURENCE M - Officer CHIEF SCIENTIFIC OFFICER

    		2023-03-14 19:38:59 -0400 2023-03-12 M 23,460 a 2,260,176 direct 1.7241 -3.4483 3.7931 5 -3.4483 6

    CORASH LAURENCE M - Officer CHIEF SCIENTIFIC OFFICER

    		2023-03-14 19:38:59 -0400 2023-03-12 M 23,460 d 0 direct

    GREEN KEVIN DENNIS - Officer CHIEF FINANCIAL OFFICER

    		2023-03-14 19:43:11 -0400 2023-03-12 M 21,667 a 443,464 direct 1.7241 -3.4483 3.7931 5 -3.4483 6

    GREEN KEVIN DENNIS - Officer CHIEF FINANCIAL OFFICER

    		2023-03-14 19:43:11 -0400 2023-03-12 M 21,667 d 21,666 direct

    GREEN KEVIN DENNIS - Officer CHIEF FINANCIAL OFFICER

    		2023-03-14 19:43:11 -0400 2023-03-12 M 23,460 a 431,459 direct 1.7241 -3.4483 3.7931 5 -3.4483 6

    GREENMAN WILLIAM MARINER - Director - Officer PRESIDENT AND CEO

    		2023-03-14 19:47:42 -0400 2023-03-12 M 64,667 d 64,666 direct

    BENJAMIN RICHARD J - Officer CHIEF MEDICAL OFFICER

    		2023-03-03 17:13:19 -0500 2023-03-01 A 160,000 a 332,665 direct -0.7117 3.9146 3.9146 6 -1.0676 4

    GREEN KEVIN DENNIS - Officer CHIEF FINANCIAL OFFICER

    		2023-03-03 17:16:30 -0500 2023-03-01 A 185,000 a 407,999 direct -0.7117 3.9146 3.9146 6 -1.0676 4

    CORASH LAURENCE M - Officer CHIEF SCIENTIFIC OFFICER

    		2023-03-03 17:14:47 -0500 2023-03-01 A 110,000 a 2,236,716 direct -0.7117 3.9146 3.9146 6 -1.0676 4

    MENARD CHRYSTAL - Officer CHIEF LEGAL OFFICER

    		2023-03-03 17:21:57 -0500 2023-03-01 A 160,000 a 324,871 direct -0.7117 3.9146 3.9146 6 -1.0676 4

    MOORE CAROL - Officer SVP REG. & QUALITY

    		2023-03-03 17:24:00 -0500 2023-03-01 A 110,000 a 393,866 direct -0.7117 3.9146 3.9146 6 -1.0676 4

    GREENMAN WILLIAM MARINER - Director - Officer PRESIDENT AND CEO

    		2023-03-03 17:17:39 -0500 2023-03-01 A 575,000 a 2,546,634 direct -0.7117 3.9146 3.9146 6 -1.0676 4

    JAYARAMAN VIVEK K - Officer CHIEF OPERATING OFFICER

    		2023-03-03 17:19:47 -0500 2023-03-01 A 240,000 a 614,226 direct -0.7117 3.9146 3.9146 6 -1.0676 4

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    CERUS CORP CERS 2023-03-31 22:15:04 UTC 4.3615 0.4585 1800000
    CERUS CORP CERS 2023-03-31 21:45:05 UTC 4.3615 0.4585 1800000
    CERUS CORP CERS 2023-03-31 21:15:03 UTC 4.3615 0.4585 1800000
    CERUS CORP CERS 2023-03-31 20:45:04 UTC 4.3615 0.4585 1800000
    CERUS CORP CERS 2023-03-31 20:15:04 UTC 4.3615 0.4585 1800000
    CERUS CORP CERS 2023-03-31 19:45:04 UTC 4.3615 0.4585 1800000
    CERUS CORP CERS 2023-03-31 19:15:04 UTC 4.3615 0.4585 1800000
    CERUS CORP CERS 2023-03-31 18:45:04 UTC 4.3615 0.4585 1800000
    CERUS CORP CERS 2023-03-31 18:15:04 UTC 4.3615 0.4585 1800000
    CERUS CORP CERS 2023-03-31 17:45:04 UTC 4.3615 0.4585 1800000
    CERUS CORP CERS 2023-03-31 17:15:03 UTC 4.3615 0.4585 1800000
    CERUS CORP CERS 2023-03-31 16:45:04 UTC 4.3615 0.4585 1800000
    CERUS CORP CERS 2023-03-31 16:15:04 UTC 4.3615 0.4585 1700000
    CERUS CORP CERS 2023-03-31 15:45:04 UTC 4.3615 0.4585 1700000
    CERUS CORP CERS 2023-03-31 15:15:03 UTC 4.3615 0.4585 1600000
    CERUS CORP CERS 2023-03-31 14:45:04 UTC 4.3615 0.4585 1600000
    CERUS CORP CERS 2023-03-31 14:15:04 UTC 4.3615 0.4585 1600000
    CERUS CORP CERS 2023-03-31 13:45:03 UTC 4.3615 0.4585 1600000
    CERUS CORP CERS 2023-03-31 13:15:03 UTC 4.3615 0.4585 1600000
    CERUS CORP CERS 2023-03-31 12:45:03 UTC 4.3615 0.4585 1600000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Index Plus All-Cap Fund CERS -21.0 shares, $-97.65 2020-03-31 N-PORT
    Prudential Investment Portfolios 12- PGIM QMA Long-Short Equity Fund CERS -5800.0 shares, $-35322.0 2021-09-30 N-PORT
    Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio CERS -68200.0 shares, $-415338.0 2021-09-30 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund CERS -2800.0 shares, $-10220.0 2022-12-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments